Cite
HARVARD Citation
Sands, B. et al. (n.d.). DOP41 Achievement of corticosteroid-free clinical endpoints in subjects with ulcerative colitis: an analysis of the phase 3 ELEVATE UC 52 trial. Journal of Crohn's and colitis. pp. i106-i107. [Online].